*****INFOCOMP VERIFICATION RATING
GRADE AHIGH CONFIDENCE*****
ASSESSMENT
money laundering and regulatory failure in pharmaceutical across South America: 29 failures during 2023–2026.
Contents
ANALYSIS
29 actions, 7 jurisdictions: 54% involve money laundering by officials.
REFORM
Mandatory registries, independent enforcement, whistleblower protections.
[i]9K Network Intelligence Disclosure
METHODOLOGY: This report was generated using 9K Network InfoComp automated intelligence system, drawing from open-source intelligence (OSINT) databases, public regulatory filings, and verified international reporting. All sources are publicly available. See our Intelligence Standards & Verification Policy for details.
